AdAlta (1AD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock 1AD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period AdAlta Limited to Showcase ‘East to West’ Strategy at Upcoming EventsSeptember 3 at 7:11 PM | tipranks.comAdAlta Ltd. Announces Quotation of New Securities on ASXAugust 27, 2025 | msn.comAdAlta Unveils Strategic ‘East to West’ Approach at TechKnow Invest ConferenceAugust 21, 2025 | msn.comAdAlta to Showcase ‘East to West’ Strategy at TechKnow Invest ConferenceAugust 18, 2025 | msn.comAdAlta Limited Announces Board Change Amid Strategic ShiftJune 30, 2025 | tipranks.comAdAlta Completes Rights Issue, Raises $1.3 MillionJune 12, 2025 | tipranks.comInsider Buyers Lose AU$92k As AdAlta Sheds AU$643kMay 30, 2025 | finance.yahoo.comAdAlta Limited Announces Capital Raising InitiativeMay 4, 2025 | tipranks.comAdAlta Limited Announces Target Market Determination for Attaching OptionsMay 4, 2025 | tipranks.comTop 10 at 11: ASX opens higher as Nasdaq jumps 1.5pc overnightMay 2, 2025 | msn.comStockTake: AdAlta eyes $1.3m boost to fuel East to West cellular immunotherapy strategyMay 1, 2025 | msn.comAdAlta Limited Launches $1.3 Million Rights Issue to Fuel GrowthApril 30, 2025 | tipranks.comEast Meets West: AdAlta navigates China–US divide to drive biotech valueApril 21, 2025 | msn.comHealth Kick Podcast: Deep dive into AdAlta’s East to West strategyApril 9, 2025 | msn.comClosing Bell: ASX up 1.2pc with power play from tech stocks, surprise dip in jobsMarch 20, 2025 | msn.comStockTake: AdAlta subsidiary AdCella secures funding boostMarch 19, 2025 | msn.comAdAlta Secures Investment to Accelerate ‘East to West’ Immunotherapy StrategyMarch 19, 2025 | tipranks.comAdAlta Limited Issues New Shares to Strengthen FundingMarch 16, 2025 | tipranks.comAdAlta to Showcase ‘East to West’ Strategy at Biopharma SummitMarch 3, 2025 | tipranks.comAdAlta Limited Reports Significant Revenue Decline in H1 2024February 20, 2025 | tipranks.comLong Shortz with AdAlta: The East to West vision for immunotherapyFebruary 10, 2025 | msn.comAdAlta Issues New Shares to Employees Under Equity PlanFebruary 6, 2025 | tipranks.comAdAlta prioritises ‘East to West’ cellular immunotherapy strategy to drive value creationFebruary 6, 2025 | msn.com'East to West': AdAlta unveils new strategy to find drug candidates, but appears to've ditched AD-214February 5, 2025 | msn.comAdAlta Limited Unveils Strategic ‘East to West’ Cellular Immunotherapy ApproachFebruary 5, 2025 | tipranks.comRoad to 2025: AdAlta’s push to advance lead drug AD-214 for deadly IPFJanuary 7, 2025 | msn.comInsider Traders Lose AU$43k As AdAlta DropsDecember 20, 2024 | uk.finance.yahoo.comWTF with 1AD: New approach to treating fibrosis with lead i-body drug candidateNovember 24, 2024 | msn.comAdAlta Limited Advances Drug Discovery and PartnershipsNovember 21, 2024 | markets.businessinsider.comAdAlta Ltd. Showcases Drug Development ProspectsNovember 21, 2024 | markets.businessinsider.comAdAlta Strengthens Board with New AppointmentsNovember 17, 2024 | markets.businessinsider.comAdAlta to Showcase Innovative Drug Discovery at TSN ConferenceOctober 30, 2024 | markets.businessinsider.comLong Shortz with AdAlta: Growing in confidence every day for fibrotic medical treatmentsOctober 28, 2024 | msn.comAdAlta Limited Strengthens Clinical and Strategic InitiativesOctober 24, 2024 | markets.businessinsider.comAdAlta secures top talent to lead AdCella and AdSolis as boost in clinical activity loomsOctober 23, 2024 | msn.comClosing Bell: WiseTech drags again; 29Metals sinks 20pc on copper outputOctober 23, 2024 | msn.comAdAlta Strengthens Leadership for Cancer and Fibrosis TherapiesOctober 23, 2024 | markets.businessinsider.comLong Shortz with AdAlta: Global health experts recruited for idiopathic pulmonary fibrosis drugOctober 10, 2024 | msn.comAdAlta forms clinical advisory board to advance IPF drug candidateOctober 9, 2024 | msn.comUp 19% in 2024, is it time to buy or sell Coles shares?September 18, 2024 | fool.com.auClosing Bell: ASX up 0.22pc after slow start; iron ore miners, REA weigh on marketSeptember 2, 2024 | msn.comHealth Kick Podcast: Creating hope for debilitating diseasesAugust 27, 2024 | msn.comLong Shortz with AdAlta: New quarter, twice the cashJuly 31, 2024 | msn.comAdAlta Ltd 1ADMay 17, 2024 | morningstar.comMLong Shortz with AdAlta: Progressive partnership to spread life-saving immunotherapiesMay 14, 2024 | msn.comMarket Highlights: Novovax doubles; Chalmers calls critical minerals a ‘golden opportunity’May 13, 2024 | msn.comAdAlta secures Cell Therapies as cellular immunotherapies manufacturerMay 13, 2024 | msn.comAdAlta locks in $3.7m to speed up Phase II clinical trials, near-term partnershipsApril 29, 2024 | msn.comLong Shortz with AdAlta: Strengthening bonds in the fight against cancerApril 8, 2024 | msn.comAdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapyApril 7, 2024 | msn.com Get AdAlta News Delivered to You Automatically Sign up to receive the latest news and ratings for 1AD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 1AD Media Mentions By Week 1AD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. 1AD News Sentiment▼0.300.71▲Average Medical News Sentiment 1AD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. 1AD Articles This Week▼10▲1AD Articles Average Week Get the Latest News and Ratings for 1AD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AdAlta and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SXTPW News Today AGNPF News Today AKBLF News Today DRTSW News Today ASPHF News Today ASCLF News Today AVCTF News Today AWKNF News Today BRRGF News Today BCTXW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:1AD) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdAlta Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share AdAlta With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
